Author

Jodie Meng

Stanford Medicine

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:chromatin & epigenetic regulation· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1 Approach:statistical model· 1

Frequent Co-Authors

Abhishek KoladiyaiD· 1 shared Alice YuiD· 1 shared Ao WangiD· 1 shared Astraea Jager· 1 shared Charles Grenfell MullighaniD· 1 shared David A. KnowlesiD· 1 shared Dorra Jedoui· 1 shared Felix J. HartmanniD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Abhishek KoladiyaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Oncogenic mutations disrupt lineage differentiation via epigenetic perturbations

Lingjun Meng, Alice Yu, Huanwei Huang, Jodie Meng, Yongjin Yoo, Katie Schaukowitch, Justyna A. Janas, David A. Knowles

This study shows oncogenic mutations disrupt lineage differentiation by altering DNA methylation, impairing stem cell reprogramming and differentiation while maintaining proliferation.

bioRxiv · Apr 22, 2025 · PreprintCell Biology

Uridine Metabolism as a Targetable Metabolic Achilles' Heel for chemo-resistant B-ALL

Yuxuan Liu, Haowen Jiang, Jingjing Liu, Lucille Stuani, Milton J. Merchant, Astraea Jager, Abhishek Koladiya, Ti‐Cheng Chang, Pablo Domizi, Jolanda Sarno, Timothy Keyes, Dorra Jedoui, Ao Wang, Jodie Meng, Felix J. Hartmann, , Kara Lynn Davis

This study identifies uridine metabolism as a therapeutic target for chemo-resistant B-ALL by linking active signaling to uridine dependency and demonstrating DHODH inhibition as a promising treatment.

bioRxiv · Jan 27, 2025 · PreprintCancer Biology